Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.


TSX:DHT.UN - Post by User

Post by SuperMon Jul 09, 2024 11:22am
142 Views
Post# 36124444

More analysts chime in

More analysts chime in

Elsewhere, CIBC cut its target price to C$18.5 from C$20; RBC cut its target price to C$16 from C$20; and Stifel cut its target price to C$15 from C$22 while downgrading its rating to “hold” from “buy”.

The average analyst target is now C$19.27, down from C$21.60 a month ago, according to LSEG data.

GLTA
SM

<< Previous
Bullboard Posts
Next >>